Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial - The Lancet Global Health
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial - The Lancet
The Lancet Commission on the future of care and clinical research in autism - The Lancet
Etrolizumab for ulcerative colitis: beyond what meets the eye - The Lancet Gastroenterology & Hepatology
Rapid triage for COVID-19 using routine clinical data for patients attending hospital: development and prospective validation of an artificial intelligence screening test - The Lancet Digital Health
Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study - The Lancet Respiratory Medicine
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study - The Lancet Public Health
Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study - The Lancet
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review - The Lancet Oncology
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology
The Lancet Clinical Practice
The Lancet, 01 February 2020, Volume 395, Issue 10221, Pages 311-388, e16-e18
Migraine: integrated approaches to clinical management and emerging treatments - The Lancet
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial - The Lancet Respiratory Medicine
Clinical and virological data of the first cases of COVID-19 in Europe: a case series - The Lancet Infectious Diseases
Alzheimer's disease: clinical trials and drug development - The Lancet Neurology
Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes - The Lancet Infectious Diseases
Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial - The Lancet
Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context - The Lancet Respiratory Medicine
The Lancet, 21 February 2015, Volume 385, Issue 9969, Pages 663-744
The Lancet - YouTube
A clinical prediction rule for ambulation outcomes after traumatic spinal cord injury: a longitudinal cohort study - The Lancet
